Clinical Trials Browser

Phase 3 × romiplostim × Classical hematology × Clear all

NCT06201663 2024-01-11

Romiplostim in Chemotherapy-Induced Thrombocytopenia

Phase 3 Unknown

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase 3 Completed

62 enrolled 16 charts 2 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic